Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD? - PubMed (original) (raw)
- PMID: 19794351
Free article
Atomoxetine may improve methylphenidates' efficacy in treatment of ADHD?
Helmut Niederhofer. Psychiatr Danub. 2009 Sep.
Free article
No abstract available
Similar articles
- Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H, Cherlin EA, Duesenberg DA, Bangs ME, Ramsey JL, Feldman PD, Allen AJ, Kelsey DK. Quintana H, et al. Clin Ther. 2007 Jun;29(6):1168-77. doi: 10.1016/j.clinthera.2007.06.017. Clin Ther. 2007. PMID: 17692731 Clinical Trial. - Improving decision making in the treatment of ADHD.
Vitiello B. Vitiello B. Am J Psychiatry. 2008 Jun;165(6):666-7. doi: 10.1176/appi.ajp.2008.08030365. Am J Psychiatry. 2008. PMID: 18519529 No abstract available. - Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.
Wang Y, Zheng Y, Du Y, Song DH, Shin YJ, Cho SC, Kim BN, Ahn DH, Marquez-Caraveo ME, Gao H, Williams DW, Levine LR. Wang Y, et al. Aust N Z J Psychiatry. 2007 Mar;41(3):222-30. doi: 10.1080/00048670601057767. Aust N Z J Psychiatry. 2007. PMID: 17464703 Clinical Trial. - Medication options when treating children and adolescents with ADHD: interpreting the NICE guidance 2006.
Harpin VA. Harpin VA. Arch Dis Child Educ Pract Ed. 2008 Apr;93(2):58-65. doi: 10.1136/adc.2006.106864. Arch Dis Child Educ Pract Ed. 2008. PMID: 18356307 Review. - Attention-deficit-hyperactivity disorder: an update.
Dopheide JA, Pliszka SR. Dopheide JA, et al. Pharmacotherapy. 2009 Jun;29(6):656-79. doi: 10.1592/phco.29.6.656. Pharmacotherapy. 2009. PMID: 19476419 Review.
Cited by
- Atomoxetine and stimulant medications in children and adolescents with persistent symptoms of attention deficit hyperactivity disorder despite monotherapy.
Jacques A. Jacques A. Can Pharm J (Ott). 2012 Sep;145(5):226-230.e1. doi: 10.3821/145.5.cpj226. Can Pharm J (Ott). 2012. PMID: 23509571 Free PMC article. No abstract available. - A systematic review of combination therapy with stimulants and atomoxetine for attention-deficit/hyperactivity disorder, including patient characteristics, treatment strategies, effectiveness, and tolerability.
Treuer T, Gau SS, Méndez L, Montgomery W, Monk JA, Altin M, Wu S, Lin CC, Dueñas HJ. Treuer T, et al. J Child Adolesc Psychopharmacol. 2013 Apr;23(3):179-93. doi: 10.1089/cap.2012.0093. Epub 2013 Apr 6. J Child Adolesc Psychopharmacol. 2013. PMID: 23560600 Free PMC article. Review. - Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.
Storebø OJ, Pedersen N, Ramstad E, Kielsholm ML, Nielsen SS, Krogh HB, Moreira-Maia CR, Magnusson FL, Holmskov M, Gerner T, Skoog M, Rosendal S, Groth C, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Håkonsen SJ, Aagaard L, Simonsen E, Gluud C. Storebø OJ, et al. Cochrane Database Syst Rev. 2018 May 9;5(5):CD012069. doi: 10.1002/14651858.CD012069.pub2. Cochrane Database Syst Rev. 2018. PMID: 29744873 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical